Camptosar Inj
FDA Approves Lymphoseek to Locate Lymph Nodes »
"The U.S. Food and Drug Administration today approved Lymphoseek (technetium Tc 99m tilmanocept) Injection, a radioactive diagnostic imaging agent that helps doctors locate lymph nodes in patients with breast cancer or melanoma who are undergoing "...
Read the FDA Approves Lymphoseek to Locate Lymph Nodes article »
Camptosar Injection
Camptosar Injection Patient Information including How Should I Take
In this Article
- What is irinotecan (Camptosar Injection)?
- What are the possible side effects of irinotecan (Camptosar Injection)?
- What is the most important information I should know about irinotecan (Camptosar Injection)?
- What should I discuss with my healthcare provider before receiving irinotecan (Camptosar Injection)?
- How is irinotecan given (Camptosar Injection)?
- What happens if I miss a dose (Camptosar Injection)?
- What happens if I overdose (Camptosar Injection)?
- What should I avoid while using irinotecan (Camptosar Injection)?
- What other drugs will affect irinotecan (Camptosar Injection)?
- Where can I get more information?
What should I discuss with my healthcare provider before receiving irinotecan (Camptosar Injection)?
You should not use irinotecan if you are allergic to it.
To make sure you can safely receive irinotecan, tell your doctor if you have any of these other conditions:
- liver or kidney disease;
- diabetes;
- asthma, chronic obstructive pulmonary disease (COPD), sleep apnea, or other breathing disorder;
- an intestinal disorder or obstruction;
- Gilbert's syndrome;
- fructose intolerance (irinotecan contains sorbitol); or
- if you are receiving radiation treatment to your abdomen or pelvic area.
FDA pregnancy category D. Do not use irinotecan if you are pregnant. It could harm the unborn baby. Use effective birth control, and tell your doctor if you become pregnant during treatment.
It is not known whether irinotecan passes into breast milk or if it could harm a nursing baby. You should not breast-feed while you are using irinotecan.
How is irinotecan given (Camptosar Injection)?
Your doctor may recommend a DNA test before your first dose of irinotecan. Some people are genetically more likely to have certain side effects from irinotecan.
Irinotecan is injected into a vein through an IV. You will receive this injection in a clinic or hospital setting. Irinotecan must be given slowly, and the IV infusion can take up to 90 minutes to complete.
You may be given other medications to prevent nausea, vomiting, diarrhea, and other side effects while you are receiving irinotecan. You may need to keep using these medications for at least a day after your irinotecan injection.
Tell your caregivers if you feel any burning, pain, or swelling around the IV needle when irinotecan is injected.
If any of the medicine gets on your skin, wash right away with soap and water.
Irinotecan can cause severe diarrhea, which can occur soon after your injection or more than 24 hours later. You can easily become dehydrated if you have ongoing diarrhea. You may also develop a severe infection or a serious electrolyte imbalance.
Your doctor may recommend you have an anti-diarrhea medicine such as loperamide (Imodium) available at all times while you are receiving irinotecan. Take the anti-diarrhea medication at the first sign of loose or frequent bowel movements.
Call your doctor if you still have diarrhea after 24 hours of taking anti-diarrhea medicine. Do not take loperamide for longer than 2 full days without your doctor's advice.
To be sure this medication is not causing harmful effects, your blood may need to be tested often. Your kidney or liver function may also need to be tested. Visit your doctor regularly.
If you need surgery, tell the surgeon ahead of time that you are using irinotecan.
Additional Camptosar Injection Information
Camptosar Injection - User Reviews
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Cancer
Get the latest treatment options.






